Plain-English translation of NCT06834269 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a treatment called transcranial static magnetic field stimulation (tSMS)—a non-invasive magnetic therapy applied to the brain—to see if it can help slow down ALS progression. Researchers will measure how well the treatment works by tracking disease progression, blood and urine markers, and brain activity. The goal is to find out whether this magnetic stimulation, combined with standard ALS medication, can make a meaningful difference for people living with ALS.
Currently, there are very limited treatment options for ALS, and the disease progresses rapidly in most patients. This trial exists to explore whether magnetic stimulation of the brain might help preserve nerve function and slow disease progression, and to identify biological markers that could help doctors personalize treatment in the future.
You likely qualify if…
You likely don't qualify if…
You would use a magnetic stimulation device at home for two 2-hour sessions each day for 12 months. Every three months, you would visit the clinic for a check-up and to provide blood and urine samples. Before and after the year-long treatment, researchers would test your brain's electrical activity using standard magnetic stimulation tests. The study team will track how your symptoms change and look for patterns in your blood work that might explain how the treatment works.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
Italy